NCT06297161View on ClinicalTrials.gov

A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).

Not yet recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Chronic Leukemia Myelogenous
Interventions
DRUG

Bosulif

chronic myelogenous leukemia patients

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT06297161 - A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML). | Biotech Hunter | Biotech Hunter